Comparative Efficacy, Safety and Tolerability of Olopatadine Extended Release Tablets and Olopatadine Immediate Release Tablets in the Treatment of Seasonal Allergic Rhinitis - A Randomized, Double-Blind Study.

Trial Profile

Comparative Efficacy, Safety and Tolerability of Olopatadine Extended Release Tablets and Olopatadine Immediate Release Tablets in the Treatment of Seasonal Allergic Rhinitis - A Randomized, Double-Blind Study.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs Olopatadine (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Registrational; Therapeutic Use
  • Sponsors Ranbaxy Laboratories
  • Most Recent Events

    • 01 Mar 2013 Status changed from not yet recruiting to completed as reported by Clinical Trials Registry - India.
    • 24 Dec 2010 Planned initiation date changed from Nov 2010 to Jan 2011 Clinical Trials Registry - India.
    • 15 Sep 2010 Planned initiation date changed from 1 Aug 2010 to 1 Nov 2010 as reported by Clinical Trials Registry - India record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top